Newlink Genetics reported $0 in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Agenus AGEN:US $ 14.18M 0.63M
Bristol Myers Squibb BMY:US $ 44972M 419M
Capricor Therapeutics CAPR:US $ 3.38M 0M
Celldex Therapeutics CLDX:US $ 0M 0M
Eli Lilly And LLY:US $ 16508.8M 375.9M
Idera Pharmaceuticals IDRA:US $ 0M 0M
Intrexon XON:US $ 201.47M 18.32M
Merk MRK:US $ 31794M 1308M
Nektar Therapeutics NKTR:US $ 0M 0M
Newlink Genetics NLNK:US $ 0M 0M
Pfizer PFE:US $ 36301M 2135M
Prothena PRTA:US $ 0M 0M
Sarepta Therapeutics SRPT:US $ 1098.85M 1.97M
Vascular Biogenics VBLT:US 0 0
YTE INCY:US $ 34.18M 0.09M